title: Primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction in a patient taking dabigatran for chronic anticoagulation.
abstract: Interventional cardiologists have few data on which to base clinical decisions regarding optimal care for ST-segment-elevation myocardial infarction patients who are taking therapeutic chronic oral anticoagulation. We present what we believe to be the first reported case of emergency coronary angiography and primary percutaneous coronary intervention in an ST-segment-elevation myocardial infarction patient who was on a dabigatran regimen for atrial fibrillation. The patient tolerated the procedures well and had no observable bleeding sequelae. In addition to the patient's case, we discuss the current evidence regarding the periprocedural management of oral anticoagulation in patients who need coronary angiography and percutaneous coronary intervention.
authors: Imdad
authors: I
authors: Ahmed
authors: Stephen J
authors: SJ
authors: Voyce
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000991:Antithrombins / Q000627:therapeutic use*; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000628:therapy; D003328:Coronary Thrombosis / Q000628:therapy; D000069604:Dabigatran / Q000627:therapeutic use*; D006801:Humans; D056989:Inferior Wall Myocardial Infarction / Q000628:therapy*; D008297:Male; D062645:Percutaneous Coronary Intervention; D015607:Stents; D017131:Thrombectomy
chemical_list: D000991:Antithrombins; D000069604:Dabigatran
keywords: Anticoagulants/administration & dosage/adverse effects/therapeutic use; clinical protocols/standards; medication therapy management/standards; myocardial infarction/therapy; myocardial revascularization; percutaneous coronary intervention; risk assessment; thrombolytic therapy; treatment outcome